Hajime Sasaki Selected Research

isomaltulose (palatinose)

9/2015	Effect of nutritional counseling and long term isomaltulose based liquid formula (MHN-01) intake on metabolic syndrome.
8/2011	A new immune-modulating diet enriched with whey-hydrolyzed peptide, fermented milk, and isomaltulose attenuates gut ischemia-reperfusion injury in mice.
9/2009	Improvement of glucose metabolism in patients with impaired glucose tolerance or diabetes by long-term administration of a palatinose-based liquid formula as a part of breakfast.
8/2007	Dietary palatinose and oleic acid ameliorate disorders of glucose and lipid metabolism in Zucker fatty rats.
6/2007	A palatinose-based balanced formula improves glucose tolerance, serum free fatty acid levels and body fat composition.
5/2007	The Anti-Obesity Effect of the Palatinose-Based Formula Inslow is Likely due to an Increase in the Hepatic PPAR-alpha and Adipocyte PPAR-gamma Gene Expressions.
4/2007	Effects of a novel palatinose based enteral formula (MHN-01) carbohydrate-adjusted fluid diet in improving the metabolism of carbohydrates and lipids in patients with esophageal cancer complicated by diabetes mellitus.
8/2004	Effect of a novel palatinose-based liquid balanced formula (MHN-01) on glucose and lipid metabolism in male Sprague-Dawley rats after short- and long-term ingestion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hajime Sasaki Research Topics

Disease

12	Inflammation (Inflammations) 11/2020 - 08/2008
11	Infections 01/2022 - 01/2004
5	Type 2 Diabetes Mellitus (MODY) 01/2016 - 04/2007
4	Hepatitis 04/2012 - 05/2006
3	Atrophy 01/2020 - 05/2012
3	Bone Resorption 01/2019 - 01/2004
3	Periodontitis 01/2019 - 05/2008
3	Body Weight (Weight, Body) 11/2012 - 08/2008
3	Obesity 07/2011 - 05/2007
3	Hyperglycemia 08/2007 - 08/2004
2	Vesico-Ureteral Reflux (Vesicoureteral Reflux) 01/2022 - 01/2017
2	Multiple Myeloma 01/2021 - 01/2019
2	Fibrosis (Cirrhosis) 01/2020 - 05/2006
2	Neoplasms (Cancer) 01/2019 - 12/2015
2	Periapical Periodontitis (Apical Periodontitis) 01/2018 - 01/2016
2	Hypertension (High Blood Pressure) 10/2016 - 01/2016
2	Non-alcoholic Fatty Liver Disease 01/2016 - 12/2014
2	Glucose Intolerance 09/2015 - 09/2009
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2015 - 06/2007
2	Reperfusion Injury 12/2014 - 08/2011
2	Hyperlipidemias (Hyperlipidemia) 11/2013 - 08/2007
2	Carcinoma (Carcinomatosis) 05/2011 - 04/2007
2	Alveolar Bone Loss 05/2008 - 12/2004
1	Autoimmune Hepatitis 12/2021
1	Autoimmune Pancreatitis 12/2021
1	Cytokine Release Syndrome 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2020
1	Pruritus (Itching) 11/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Osteomyelitis 02/2019
1	Delayed Graft Function 12/2018
1	Chronic Hepatitis B 10/2018
1	Hepatocellular Carcinoma (Hepatoma) 10/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Rheumatoid Arthritis 11/2016
1	Osteonecrosis (Kienbock's Disease) 11/2016
1	Multiple Sclerosis 11/2016
1	Cytomegalovirus Infections (Inclusion Disease) 07/2016
1	Alcoholic Fatty Liver 01/2016
1	Coinfection 01/2016

Drug/Important Bio-Agent (IBA)

10	CytokinesIBA 01/2019 - 01/2004
8	isomaltulose (palatinose)IBA 09/2015 - 08/2004
7	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 08/2004
5	Peptides (Polypeptides)IBA 12/2014 - 07/2011
3	Interleukin-10 (Interleukin 10)IBA 02/2019 - 12/2004
3	LipidsIBA 05/2017 - 04/2007
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2014 - 05/2006
3	CarbohydratesIBA 08/2007 - 08/2004
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 07/2012
2	Immunoglobulins (Immunoglobulin)IBA 12/2021 - 01/2010
2	Biological ProductsIBA 01/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2008
2	Sucrose (Saccharose)IBA 01/2016 - 08/2007
2	Fluorouracil (Carac)FDA LinkGeneric 12/2015 - 02/2015
2	Insulin (Novolin)FDA Link 09/2015 - 08/2008
2	DextrinsIBA 09/2015 - 09/2009
2	Biomarkers (Surrogate Marker)IBA 09/2015 - 11/2012
2	Interleukin-6 (Interleukin 6)IBA 11/2012 - 07/2011
2	Concanavalin AIBA 04/2012 - 08/2011
2	Whey ProteinsIBA 04/2012 - 05/2006
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2011 - 05/2006
2	Interleukin-12 (IL 12)IBA 05/2008 - 01/2004
2	Interleukin-1 (Interleukin 1)IBA 12/2004 - 01/2004
1	HydrogelsIBA 01/2022
1	gelatin methacryloylIBA 01/2022
1	InterferonsIBA 01/2021
1	Histones (Histone)IBA 01/2021
1	calcipotriene (calcipotriol)FDA LinkGeneric 11/2020
1	Prostaglandins AIBA 11/2020
1	betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric 11/2020
1	Azithromycin (Zithromax)FDA LinkGeneric 11/2020
1	Calcineurin InhibitorsIBA 01/2020
1	Hypoxia-Inducible Factor 1IBA 02/2019
1	ArginaseIBA 02/2019
1	Toll-Like Receptor 2IBA 02/2019
1	UbiquitinsIBA 01/2019
1	ChemokinesIBA 01/2019
1	Macrophage Migration-Inhibitory FactorsIBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 10/2018
1	Oxygen (Dioxygen)IBA 01/2018
1	dihydroceramideIBA 05/2017
1	Virulence Factors (Pathogenicity Factors)IBA 05/2017
1	CD100 antigenIBA 11/2016
1	Ganciclovir (Cytovene)FDA LinkGeneric 07/2016
1	Foscarnet FDA LinkGeneric 07/2016
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2016
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2016
1	NF-kappa B (NF-kB)IBA 01/2016
1	Linoleic Acid (Linoleate)IBA 01/2016

Therapy/Procedure

5	Therapeutics 01/2021 - 11/2012
3	Kidney Transplantation 01/2022 - 05/2012
2	Transplantation 01/2017 - 05/2012
2	Drug Therapy (Chemotherapy) 12/2015 - 02/2015
1	Injections 01/2022
1	Immunomodulation 11/2020
1	Prostatectomy (Retropubic Prostatectomy) 01/2020
1	Warm Ischemia 12/2018
1	Organ Transplantation 07/2016